Key facts
- It has raised $1.8M.
- Notable investors include MedTech Innovator, Angel Physicians Fund, EmPOWERED to Serve Business Accelerator, SCP Ventures, Unorthodox Ventures.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for ConKay Medical Systems
- ·The full record, as it builds
Funding rounds
No funding rounds for ConKay Medical Systems are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About ConKay Medical Systems
Developer of a medical device designed to offer valvular regurgitation in patients with progressive heart failure. The company's device is based on annular repair technology to treat the main cause of functional regurgitation leaving the healthy leaflets intact to perform the way it was intended, enabling healthcare professionals to advance cardiovascular care.
- Sector
- Healthcare
- HQ
- Pleasanton, CA, United States
- Founded
- 2021
- Employees
- 3
- Website
- conkaymedical.com/
- Ownership
- Privately Held (backing)
ConKay Medical Systems doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in ConKay Medical Systems shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on ConKay Medical Systems in its N-PORT filings yet. We sweep new filings monthly.